News
trū® Chitosan, a brand of iterro Life Sciences, announced the introduction of trū Chitosan USP Inhalant—the first commercially available chitosan qualified for inhaled drug delivery, based on ...
Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and Drug Administration (FDA).
trū Chitosan USP Inhalant joins the offerings of trū Chitosan to serve a variety of medical applications as an excipient, adjuvant, and active ingredient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback